SprintRay, manufacturer of high-tech fabrication solutions for dental professionals, and BEGO, the Bremen-based dental materials specialist with over 130 years of dental experience and more than 20 years of expertise in the field of dental 3D printing, today formally announce their integration partnership. This new integration will see the VarseoSmile Crown plus and VarseoSmile Temp materials become available for use with the SprintRay Pro 3D printing ecosystem, starting in the U.S. market.

Fluidx Medical Technology announced GPX Embolic Device first patient use cases were presented at the Leipzig Interventional Course (LINC) in Leipzig, Germany (https://linc.live-events.live/on-demand/dq2GmM8LqnsqQJfgc). "This is very promising technology," said Andrew Holden, M.D., MBChB, FRANZCR, EBIR, ONZM, Director of Interventional Radiology, Auckland City Hospital, Auckland, New Zealand.  "The very radiopaque GPX penetrates distally extremely well with excell

Health industry digitalization is one of the highest priorities in the healthcare sector these times. In perspective, it improves current living standards with quicker and easier access to help. The Healthcare Automation and Digitalization Congress business program will cover digital trends in the healthcare industry. The Congress will take place in Zurich, Switzerland on the 27th– 28th of September, 2021. Growth of pharmaceutical costs, poorly integrated doctor-patient intera

X-Bolt Orthopaedics, a leading orthopaedic device company, highlights key results data from the WHITE4 trial, published in February's Bone & Joint Journal, comparing the company's flagship X-Bolt® XHS versus the gold standard Sliding Hip Screw. WHITE4 was the world's largest randomised trial in hip fracture fixation (n=1,128) across ten UK specialist orthopaedic centres. Sliding Hip Screw (SHS) fixation is a well-established treatment of trochanteric hip fracture

Galderma announces that the U.S. Food and Drug Administration (FDA) has approved Restylane® Defyne for the augmentation and correction of mild to moderate chin retrusion for adults over the age of 21.1 In 2020 alone, online searches for chin enhancement increased by 185 percent, reinforcing the emerging patient need for a product like Restylane Defyne.2 Restylane Defyne is the first and only chin filler to demonstrate results* across a wide range of participants†, including partici

Althea UK and Ireland – the leading medical technology services provider– has announced that they are now offering high quality and cost-effective SARS-CoV-2 Rapid Antigen Tests.                                             The antibody test – manufacture

Edwards Lifesciences announced new data from the COMMENCE clinical trial that demonstrate Edwards' bioprosthetic surgical aortic valve with the company's novel RESILIA tissue platform show favorable safety and hemodynamic performance through a median of five years follow-up. The data were presented at the 57th annual meeting of the Society of Thoracic Surgeons. "There continues to be a significant focus placed on tissue valve durability given the increase in life expect

Banjo Health, a startup leader in AI-driven prior authorization solutions, today is pleased to announce the signing of a multi-year agreement with ELMCRx Solutions, LLC, a pharmacy benefits management and cost containment firm located in Pennsylvania, to enhance existing prior authorization management and reporting practices through intelligent, clinician-focused solutions. Effective Mar. 1, 2021, Banjo Health will provide its comprehensive PA Management solution, Harmony PA, to ELM

Medovate has announced a newly formed partnership with Konica Minolta Healthcare Americas, Inc. to promote best practice within regional anaesthesia across the United States and the Middle East. The partnership will highlight the provision of Ultrasound Guided Regional Anaesthesia’ and how the revolutionary SAFIRA® (SAFer Injection for Regional Anaesthesia) can be used in conjunction with Konica Minolta Healthcare Americas’ Inc. range of pioneering ultrasound solutio

Neurolief Ltd., a neurotechnology innovator, today announces that it has entered into an exclusive agreement with Sawai Pharmaceutical Co., Ltd. for the development and marketing of Relivion®, a non-invasive digital medical device for migraine and depression, in Japan. Relivion® is a non-invasive brain neuromodulation* device that is placed around the head and delivers unparalleled stimulation to the occipital and trigeminal nerves. This creates a cumulative effect by releas